Byetta Injection Given Under The Skin To Control Type 2 Diabetes
A Byetta dose is typically given as an injection under the skin. A doctor or pharmacist can provide specific instructions as to how and where to use the pen, which comes in two strengths (5 micrograms (mcg), and a stronger dose in 10 mcg). There are also a number of precautions that patients should keep in mind after receiving a prescription: Use it exactly as prescribed, following the directions on the label Do not use in larger amounts or for a longer time period than recommended Do not administer immediately after eating a meal Never share the pen with another person Check your blood sugar levels regularly Use for no more than 30 days, and then discard Avoid drinking alcohol while taking this medicine Inform your doctor of all other drugs that you are using, including over-the-counter vitamins or minerals
Failure to take the correct Byetta dose can result in serious injury. However, while using the proper amount of drug, you should also seek medical attention immediately if you experience any of these mild adverse reactions after the proper medication administration. If you experience any of the maladies listed above, contact your health care professional immediately, as they may be early indicators of a deadly disease known as pancreatitis. Altering your Byetta dose without seeking the advice of a doctor can lead to this serious illness, which could also lead to hospitalization, or even death. More extreme interactions are generally characterized by internal bleeding, drastically altered blood pressure, or elevated heart and respiratory rates. They may also include some or all of the following: Shock Low calcium High blood glucose Dehydration Kidney failure Respiratory complications Systemic inflammatory response syndrome (SIRS) Infection of the organ bed
Symptoms associated with the medication are typically acute, meaning that they can appear suddenly, in their worst form. Because these interactions are so severe, in 2007, the Food and Drug Administration (FDA) ordered the manufacturers and marketers to improve warning labels that come with prescriptions. This means that, while the drug is still distributed, patients will have more information about the risks of using this particular form of therapy to control their diabetes. The FDA recommendations came after identifying at least 30 confirmed cases of pancreatitis that were directly linked to using the medication, which is made by the giant pharmaceutical corporations Amylin Pharmaceuticals and Eli Lilly and Company. This news is especially troubling to the diabetics that use the medication daily. The prescription Byetta diabetes medication was released in 2005 to address patients that were not responding well to the more common oral medicines available on the market. Although many patients do not have any adverse reactions to the medication at all, victims of pancreatitis that need or prefer a drug that is not taken orally may be troubled to learn that their diabetes medicine could lead to a life-threatening malady.
|